Riordan Technologies

Riordan Technologies is a biotechnology company at the forefront of regenerative medicine, specifically focusing on the therapeutic potential of stem cells and biologics. Founded by Dr. Neil Riordan, the company develops proprietary methods for isolating and expanding mesenchymal stem cells derived from umbilical cord tissue. These technologies are primarily applied to treat orthopedic conditions, autoimmune diseases, and chronic inflammatory disorders. Riordan Technologies operates in close coordination with the Riordan Medical Institute to translate laboratory research into clinical treatments. Their product portfolio includes advanced cellular grafts and amniotic-derived biologics designed to enhance the body's natural healing processes. The company is recognized for its contributions to the standardization and safety of umbilical cord-derived cellular products.